0001209191-19-031450.txt : 20190520 0001209191-19-031450.hdr.sgml : 20190520 20190520170820 ACCESSION NUMBER: 0001209191-19-031450 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190516 FILED AS OF DATE: 20190520 DATE AS OF CHANGE: 20190520 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MARCUS JOEL S CENTRAL INDEX KEY: 0001216955 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38898 FILM NUMBER: 19839696 MAIL ADDRESS: STREET 1: C/O ALEXANDRIA REAL ESTATE EQUITIES, INC STREET 2: 385 E. COLORADO BLVD. SUITE 299 CITY: PASADENA STATE: CA ZIP: 91101 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Applied Therapeutics Inc. CENTRAL INDEX KEY: 0001697532 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 340 MADISON AVENUE STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10173 BUSINESS PHONE: 212-220-9319 MAIL ADDRESS: STREET 1: 340 MADISON AVENUE STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10173 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-05-16 0 0001697532 Applied Therapeutics Inc. APLT 0001216955 MARCUS JOEL S C/O APPLIED THERAPEUTICS, INC. 340 MADISON AVENUE, 19TH FLOOR NEW YORK NY 10173 1 0 0 0 Common Stock 2019-05-16 4 C 0 110497 A 119668 D Common Stock 2019-05-16 4 C 0 135192 A 254860 D Common Stock 2019-05-16 4 P 0 150000 10.00 A 404860 D Series A Preferred Stock 2019-05-16 4 C 0 110497 0.00 D Common Stock 110497 0 D Series B Preferred Stock 2019-05-16 4 C 0 135192 0.00 D Common Stock 135192 0 D Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Issuer's common stock, without payment of additional consideration, on a one-for-one basis, immediately upon the closing of the Issuer's initial public offering on May 16, 2019. /s/ Jason Minio, Attorney-in-Fact 2019-05-20